Photoswitch drug shows early signs of restoring light sensitivity in severely damaged retinas in first human trial. Adelaide University researchers have carried out the first in-human trial of a new type of treatment for a leading cause of blindness in working age adults, with promising results.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: Adelaide University researchers have carried out the first in-human trial of a new type of treatment for a leading cause of blindness in working age adults, with promising results.
- Ponto de atenção: photoswitch.
- Ponto de atenção: drug.
- Ponto de atenção: shows.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.
